Latest Posts
-
CEO Espresso Interview: Jesper Carvalho Andersen
+++ Deutsche Version: siehe unten; German version below +++ Question: What is the key to your success as a leader? Two things, and they work together. The first is what I would call being a cultural bridge builder. I speak eight languages, not all at the same level, but whenever I went into a turnaround,…
-
Turning Antibody Innovation into Real-World Value
日本語版は下記をご覧ください A Pharma Talks Interview with Yo (Max) Amakusa, CEO of iBody 1. The evolution of iBody Jens Kurth: iBody initially focused on therapeutic antibodies before successfully expanding into diagnostic antibodies. What led to this strategic shift, and what opportunities did you see that others perhaps overlooked? Amakusa-san: Initially, our goal was to use our…
-
Pharma Talks: Science Opens the Door – Execution Creates Value
A Conversation with Dr. Bettina Ernst on Biotech Investing, Company Building and the Future of Innovation 26 August 2026 The Investment Landscape Pharma Talks: The biotech investment environment has changed significantly over the past decade. From your perspective, what are the most important changes in how investors evaluate opportunities today? Dr. Bettina Ernst: “I think…